Neurogene (NGNE) Other Non-Current Assets (2013 - 2026)
Neurogene (NGNE) posted Other Non-Current Assets of $1.1 million for Q1 2026, up 217.99% on a QoQ basis from $339000.0 in Q4 2025, and up 20.31% year-over-year from $896000.0 in Q1 2025.
Neurogene (NGNE) Other Non-Current Assets (2013 - 2026) Analysis & Trends
Neurogene's Other Non-Current Assets history runs 11 years deep, the most recent figure standing at $1.1 million for Q1 2026.
- Quarterly Other Non-Current Assets rose 20.31% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 20.31% YoY) and the FY2025 annual result came in at $339000.0, down 65.23% from the prior year.
- Other Non-Current Assets was $1.1 million for Q1 2026 at Neurogene, up from $339000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $2.0 million in Q2 2022 and bottomed at $300000.0 in Q2 2024.
- A 5-year average of $917375.0 and a median of $842500.0 in 2024 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2023 — Other Non-Current Assets sank 73.81% — and 2025, when it jumped 164.31%.
- Neurogene's Other Non-Current Assets stood at $1.9 million in 2022, then sank by 60.04% to $764000.0 in 2023, then grew by 27.62% to $975000.0 in 2024, then tumbled by 65.23% to $339000.0 in 2025, then jumped by 217.99% to $1.1 million in 2026.
- Business Quant data shows NGNE's Other Non-Current Assets at $1.1 million in Q1 2026, $339000.0 in Q4 2025, and $1.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Neurogene | 17.50 Mn | 17.50 Mn | - | 1.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.08 Mn |
| Dec 31, 2025 | 339,000.00 |
| Sep 30, 2025 | 1.06 Mn |
| Jun 30, 2025 | 300,000.00 |
| Mar 31, 2025 | 896,000.00 |
| Dec 31, 2024 | 975,000.00 |
| Sep 30, 2024 | 789,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Mar 31, 2024 | 339,000.00 |
| Dec 31, 2023 | 764,000.00 |
| Sep 30, 2023 | 524,000.00 |
| Jun 30, 2023 | 529,000.00 |
| Mar 31, 2023 | 905,000.00 |
| Sep 30, 2022 | 1.91 Mn |
| Jun 30, 2022 | 2.02 Mn |
| Mar 31, 2022 | 1.95 Mn |
| Dec 31, 2021 | 1.93 Mn |
| Sep 30, 2021 | 1.99 Mn |
| Jun 30, 2021 | 1.93 Mn |
| Mar 31, 2021 | 1.92 Mn |